Evidence map›Paper›PMID 27671446›Full record

ArticleScientific reports2016

Characterization of aerosols containing Legionella generated upon nebulization.

Séverine Allegra, Lara Leclerc, Pierre André Massard, Françoise Girardot, Serge Riffard, Jérémie Pourchez

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 61 citations in OpenAlex.

  1. 'Epidemiology ofMicrobial genomics · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Risk Exposure toInternational journal of environmental research and public health · 2022
    Article
  10. MIP FromFrontiers in cellular and infection microbiology · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Factors InfluencingPathogens (Basel, Switzerland) · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Evaluation of Exposure toJournal of aerosol science · 2017
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Séverine AllegraUniversity of Lyon, UJM-Saint-Etienne, CNRS, EVS-ISTHME UMR 5600, F42023 Saint-Etienne, France.
Lara LeclercUniversity of Lyon, Ecole Nationale Supérieure des Mines-Saint-Etienne, CIS-EMSE, SAINBIOSE, INSERM U1059, F-42023 Saint Etienne, France.
Pierre André MassardUniversity of Lyon, Ecole Nationale Supérieure des Mines-Saint-Etienne, CIS-EMSE, SAINBIOSE, INSERM U1059, F-42023 Saint Etienne, France.
Françoise GirardotUniversity of Lyon, UJM-Saint-Etienne, CNRS, EVS-ISTHME UMR 5600, F42023 Saint-Etienne, France.
Serge RiffardUniversity of Lyon, UJM-Saint-Etienne, CNRS, EVS-ISTHME UMR 5600, F42023 Saint-Etienne, France.
Jérémie PourchezUniversity of Lyon, Ecole Nationale Supérieure des Mines-Saint-Etienne, CIS-EMSE, SAINBIOSE, INSERM U1059, F-42023 Saint Etienne, France.
Université Claude Bernard Lyon 1 · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Legionella pneumophila is, by far, the species most frequently associated with Legionnaires' disease (LD). Human infection occurs almost exclusively by aerosol inhalation which places the bacteria in juxtaposition with alveolar macrophages. LD risk management is based on controlling water quality by applying standardized procedures. However, to gain a better understanding of the real risk of exposure, there is a need (i) to investigate under which conditions Legionella may be aerosolized and (ii) to quantify bacterial deposition into the respiratory tract upon nebulization. In this study, we used an original experimental set-up that enables the generation of aerosol particles containing L. pneumophila under various conditions. Using flow cytometry in combination with qPCR and culture, we determined (i) the size of the aerosols and (ii) the concentration of viable Legionella forms that may reach the thoracic region. We determined that the 0.26-2.5 μm aerosol size range represents 7% of initial bacterial suspension. Among the viable forms, 0.7% of initial viable bacterial suspension may reach the pulmonary alveoli. In conclusion, these deposition profiles can be used to standardize the size of inoculum injected in any type of respiratory tract model to obtain new insights into the dose response for LD.

Identifiers

PMID27671446
PMCPMC5037422
OpenAlexW2525532000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.